Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Prospective Clinical Trial Evaluating the Effect of Meso Wound Matrix in the Treatment of Chronic Non-healing Diabetic Foot Ulcers (DFUs).

NCT04182451 is registered in ClinicalTrials.gov with SerenaGroup, Inc. as lead sponsor.

NCT NCT04182451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04182451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Prospective Clinical Trial Evaluating the Effect of Meso Wound Matrix in the Treatment of Chronic Non-healing Diabetic Foot Ulcers (DFUs).
Lead sponsor
SerenaGroup, Inc.
Phase
Not applicable
Overall status
Completed
Start date
December 5, 2019
Completion date
March 1, 2023
Enrollment
30 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcers (dfus)